Contineum Therapeutics (CTNM) Assets (2023 - 2026)
Contineum Therapeutics (CTNM) posted quarterly Assets of $250.4 million for Q2 2026, up 36.9% year-over-year from $182.9 million in Q2 2025, and down 4.2% quarter-over-quarter from $261.3 million in Q1 2026.
Contineum Therapeutics (CTNM) Assets (2023 - 2026) Analysis & Trends
Contineum Therapeutics' Assets history runs 4 years deep, the most recent figure standing at $250.4 million for Q2 2026.
- In Q2 2026, Assets rose 36.9% year-over-year to $250.4 million; the TTM figure through Jun 2026 stood at $250.4 million (up 36.9% YoY), while the FY2025 annual figure was $276.6 million, up 29.97% from the prior year.
- Assets for Q2 2026 stood at $250.4 million, down from $261.3 million in the prior quarter.
- The five-year high for Assets was $276.6 million in Q4 2025, with the low at $123.6 million in Q1 2024.
- The 4-year median for Assets is $212.8 million (2024), against an average of $205.9 million.
- The sharpest annual moves came in 2024 and 2025: Assets surged 63.24% in 2024, then slipped 17.38% in 2025.
- Contineum Therapeutics' Assets stood at $130.4 million in 2023, then surged by 63.24% to $212.8 million in 2024, then grew by 29.97% to $276.6 million in 2025, then dropped by 9.5% to $250.4 million in 2026.
- Business Quant data shows CTNM's Assets at $250.4 million in Q2 2026, $261.3 million in Q1 2026, and $276.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Contineum Therapeutics | 533.73 Mn | 533.73 Mn | - | 250.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 250.37 Mn |
| Mar 31, 2026 | 261.35 Mn |
| Dec 31, 2025 | 276.64 Mn |
| Sep 30, 2025 | 190.85 Mn |
| Jun 30, 2025 | 182.89 Mn |
| Mar 31, 2025 | 198.26 Mn |
| Dec 31, 2024 | 212.85 Mn |
| Sep 30, 2024 | 216.03 Mn |
| Jun 30, 2024 | 221.36 Mn |
| Mar 31, 2024 | 123.56 Mn |
| Dec 31, 2023 | 130.39 Mn |